Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL22204560

CN(C)c1ccc2c(-c3ccc(C(=O)O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1.O=C([O-])C(F)(F)F

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RY6 Q15077 1/20 0.62
▸ MEN1 O00255 1/20 0.56
▸ THRB P10828 1/20 0.56
▸ RECQL P46063 1/20 0.56
▸ BLM P54132 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ TDP1 Q9NUW8 1/20 0.56
▸ CA12 O43570 3/20 0.52
▸ CA1 P00915 3/20 0.52
▸ CA2 P00918 3/20 0.52
▸ CA9 Q16790 3/20 0.52
▸ ITPR1 Q14643 1/20 0.50
▸ P2RY2 P41231 1/20 0.45
▸ HTR3A P46098 1/20 0.45
▸ GBA1 P04062 2/20 0.45
▸ CHRM2 P08172 2/20 0.44
▸ CHRM4 P08173 2/20 0.44
▸ CHRM5 P08912 2/20 0.44
▸ CHRM1 P11229 2/20 0.44
▸ CHRM3 P20309 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10293759 0.93 P2RY6 (0.64) P2RY6MEN1THRBRECQLBLM
SCHEMBL22204520 0.90 P2RY6 (0.69) P2RY6MEN1THRBRECQLBLM
SCHEMBL31756958 0.90 P2RY6 (0.69) P2RY6MEN1THRBRECQLBLM
SCHEMBL12716296 0.87 P2RY6 (0.62) P2RY6MEN1THRBRECQLBLM
SCHEMBL29631727 0.87 P2RY6 (0.65) P2RY6MEN1THRBRECQLBLM
SCHEMBL18286480 0.86 P2RY6 (0.60) P2RY6MEN1THRBRECQLBLM
SCHEMBL18713197 0.86 MEN1 (0.62) P2RY6MEN1THRBRECQLBLM
SCHEMBL25343641 0.85 P2RY6 (0.65) P2RY6MEN1THRBRECQLBLM
SCHEMBL14049043 0.85 P2RY6 (0.67) P2RY6MEN1THRBRECQLBLM
SCHEMBL14263356 0.85 P2RY6 (0.60) P2RY6MEN1THRBRECQLBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11512084-B2 Degradation agent using autophagic mechanism of damaged mitochondria TOHOKU UNIVERSITY (JP) 2022-11-29 — — US disclosed
US-20200223848-A1 DEGRADATION AGENT USING AUTOPHAGIC MECHANISM OF DAMAGED MITOCHONDRIA TOHOKU UNIVERSITY (JP) 2020-07-16 — — US disclosed
EP-3679935-A1 DEGRADATION AGENT USING AUTOPHAGIC MECHANISM OF DAMAGED MITOCHONDRIA Tohoku University (JP) 2020-07-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200223848-A1 DEGRADATION AGENT USING AUTOPHAGIC MECHANISM OF DAMAGED MITOCHONDRIA HSPA9, ATG7, TFAM P2RY6 3979/4885MEN1 3688/4885THRB 2718/4885
US-11512084-B2 Degradation agent using autophagic mechanism of damaged mitochondria HSPA9, ATG7, TFAM P2RY6 3979/4885MEN1 3688/4885THRB 2718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback